ArticleIrish journal of medical science2026
Molecular dynamics simulation of a novel multi-epitope vaccine design against Salmonella enterica paratyphi A using a computational approach.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salmonella enterica serovar Paratyphi A is a significant pathogen responsible for enteric fever, particularly in developing countries, contributing to high morbidity and mortality. Current vaccines predominantly target S. Typhi, leaving a critical gap in protection against Paratyphi A strains. The absence of an effective vaccine for Paratyphi A is a significant public health concern, given its potential for outbreaks and long-term healthcare burdens. Designing a targeted vaccine is essential to reduce the incidence of enteric fever and improve global health outcomes. This study focuses on developing a multi-epitope mRNA-based vaccine against S. enterica Paratyphi A using in silico approaches, which can provide a rapid, cost-effective solution for vaccine development. A comprehensive in silico approach was utilized to design a multi-epitope vaccine candidate. Epitopes for major histocompatibility complex (MHC) Class I and II were predicted using the Immune Epitope Database (IEDB), with population coverage analysis conducted to evaluate potential efficacy across diverse populations. The selected epitopes were combined into a chimeric construct, followed by 3D modeling and molecular docking studies with Toll-like receptors (TLR4 and TLR6) using ClusPro. The stability and interaction dynamics of the vaccine-receptor complexes were further assessed through molecular dynamics (MD) simulations using the iMODS server. The population coverage analysis indicated that the vaccine epitopes provided 86.62% coverage for MHC Class I, 82% for MHC Class II, and an impressive 97% combined coverage. Docking studies revealed strong binding affinities, with interaction energy scores of -1418.2 and - 1446.1 for TLR4 and TLR6, respectively. MD simulations confirmed the stability of the vaccine-receptor complexes, with favorable interaction profiles and low energy levels, suggesting strong potential for immune activation. The computational results indicate strong antigenicity and immunogenicity, providing a foundation for further experimental validation of an effective preventive strategy against enteric fever.
Indexed as
Identifiers
41493747What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.